Rock Band of Gynecologic Oncologists Connects with Patients Through Music

A rock band made up of gynecologic oncologists is connecting with patients and their fans through rock music.
BY LAURA PANJWANI
PUBLISHED: DECEMBER 05, 2016
“No evidence of disease.”

This simple phrase may not mean much to the average person, but for oncologists and the patients they treat, it’s cause for celebration.

The phrase, often abbreviated as N.E.D., is commonly written on a patient’s chart to signify that he or she has achieved remission.

It is also the name of a unique rock band made up of six gynecologic oncology surgeons, who have raised over $500,000, been the subject of an award-winning documentary and released three studio albums of original music—all to spread awareness of cervical, ovarian, uterine/endometrial, vaginal, vulvar and other gynecologic cancers.

“A lot of our patients feel they are overshadowed by the sister cancer, breast cancer, which gets so much attention,” said William Winter, M.D., gynecologic oncologist at Compass Oncology, and a guitarist for N.E.D. “We want to be their voice; we want to amplify them.”

Becoming N.E.D.

The group began in 2008, when Winter and Nimesh Nagarsheth, M.D., a gynecological oncologist at Mount Sinai Medical Center and Englewood Hospital and Medical Center, were approached by G. Larry Maxwell, M.D., a mutual friend of theirs and a leader in their field, to put together a musical show for the upcoming Society of Gynecologic Oncology meeting. Excited by the idea, Winter and Nagarsheth, who plays the drums, reached out to a few friends and colleagues who also played instruments, and quickly formed a band. After a day of rehearsal together, the newly formed group performed a two-hour set of cover songs at the event. The concert went better than expected, said Nagarsheth.

“We played and had a great time, and we basically brought down the house,” he said.

Word of the group’s success quickly spread, and soon they were invited to play at numerous industry conferences across the country. Then, an unexpected invitation came from political leaders asking them to perform in Washington D.C. as part of a gynecologic cancer awareness event the following year.

“They suggested to us that it would be a great way to promote women’s gynecologic awareness,” said Nagarsheth. “We liked that idea, but we thought that going to Washington D.C. and playing cover songs would be kind of silly.”

So the group began writing original songs, working together on lyrics and music, despite living all across the country. Soon they had created and perfected six songs, inspired by their own experiences as gynecological oncologists, and were ready to perform in Washington D.C. It was a big accomplishment, but the musician-doctors had even bigger dreams—recording an album to raise money and spread awareness of their cause.



Talk about this article with other patients, caregivers, and advocates in the Ovarian Cancer CURE discussion group.
x-button
Special Feature
Share Your Art
Related Articles
Do Genes and Gender Play a Role in Chemotherapy-Related Fatigue?
Genetics may play a role in chemotherapy-related fatigue, according to a recent study.
Can Treatment at a Large Cancer Center Mitigate Racial Disparities in Ovarian Cancer?
Studies have shown that African American women tend to have worse outcomes after ovarian cancer surgery than their white counterparts. 
New Maintenance Therapy for Ovarian Cancer Seeks FDA Approval
The pharmaceutical company Clovis Oncology filed a supplemental new drug application (sNDA) to the FDA for their drug Rubraca (rucaparib) to be used as maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
Related Videos
Expert Discusses Exciting Advances in Ovarian Cancer
Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer. 
The Importance of Seeing an Ovarian Cancer Specialist
Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.  
Dr. Boulay Discusses Removing a 140-Pound Tumor
Richard Boulay, M.D., chief of the division of Gynecologic Oncology at the Lehigh Valley Health Netowrk, tells the story of removing a 140-pound tumor from Mary Clancy. The tumor had been growing for at least 10 years when it was caught by a CAT scan, and was about half her body weight.
x
//For side ad protocol